T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer

Julia Paleckia Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USAView further author information

Amman Bhasina Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USAView further author information

Andrew Bernsteina Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USAView further author information

Patrick J. Milleb Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA, USAView further author information

William J. Testerb Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA, USAView further author information

Wm. Kevin Kellyb Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA, USAView further author information

Kevin K. Zarrabib Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA, USACorrespondence[email protected]

https://orcid.org/0000-0002-9351-2317 View further author information

show all

T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date